EC Number |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
---|
4.3.3.7 | -999 |
- |
- |
33902, 33905, 33907, 33908, 33911, 33915, 664244 |
4.3.3.7 | 100 |
- |
- |
33909 |
4.3.3.7 | 458 |
- |
- |
33906 |
4.3.3.7 | 14.52 |
- |
20.7fold purified mutant T44S |
702479 |
4.3.3.7 | 1.61 |
- |
2fold purified enzyme |
701550 |
4.3.3.7 | -999 |
- |
analysis of ability of rhizopines to interact with MosA protein in the presence and absence of methyl donors, no methyltransferase activity observed in the presence of scyllo-inosamine and S-adenosylmethionine (SAM), presence of rhizopine compounds does not affect kinetics of dihydrodipicolinate synthesis |
691786 |
4.3.3.7 | -999 |
- |
archetypal subunit orientation in the crystal structure of other dihydrodipicolinate synthase enzymes not observed, structure refinement will provide information regarding the structural evolution of dihydrodipicolinate synthase and the design of antibiotics targeting lysine biosynthesis in Staphylococcus aureus |
690266 |
4.3.3.7 | -999 |
- |
attempt to examine the specificity of the active site of DHDPS, co-crystallization with the substrate analogue oxaloacetate, solution of the protein structure indicates that pyruvate rather than oxaloacetic acid bounds in the active site, decarboxylation of oxaloacetate not catalysed by DHDPS, rate of pyruvate production independent of DHDPS concentration, indicating that the decarboxylation of oxaloacetate is occurring by a spontaneous and enzyme-independent mechanism, confirmed by kinetic analysis |
690252 |
4.3.3.7 | 0.81 |
- |
crude extract |
701550 |
4.3.3.7 | 0.72 |
- |
crude extract of mutant T44S |
702479 |